TY - JOUR
T1 - Complementation Analysis of Patients with Intact Peroxisomes and Impaired Peroxisomal β-Oxidation
AU - Mcguinness, M. C.
AU - Moser, A. B.
AU - Pollthe, B. T.
AU - Watkins, P. A.
PY - 1993/4
Y1 - 1993/4
N2 - Complementation analysis, using peroxisomal β-oxidation of very long chain fatty acids (VLCFA) as the criterion for complementation, is useful in the study of patients who are suspected of having a single enzyme defect in the peroxisomal β-oxidation pathway. Laboratory findings for these patients include elevated plasma VLCFA and impaired VLCFA oxidation in fibroblasts. Some of these patients have slightly abnormal phytanic acid oxidation in fibroblasts. In addition, elevated levels of bile acid intermediates have been reported in some cases. Plasmalogen synthesis, pipecolic acid levels, and subcellular distribution of catalase are normal. Using complementation analysis, we show that six patients. who were suspected of having a single enzyme defect in the peroxisomal β-oxidation pathway, are deficient in peroxisomal bifunctional enzyme [enoyl-CoA hydratase (EC 4.2.1. 17)/3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)] activity. This group of six patients, deficient in bifunctional enzyme activity, may be subdivided into two complementation groups. It would appear that patients in each of these two groups are deficient in only one of the bifunctional enzyme activities.
AB - Complementation analysis, using peroxisomal β-oxidation of very long chain fatty acids (VLCFA) as the criterion for complementation, is useful in the study of patients who are suspected of having a single enzyme defect in the peroxisomal β-oxidation pathway. Laboratory findings for these patients include elevated plasma VLCFA and impaired VLCFA oxidation in fibroblasts. Some of these patients have slightly abnormal phytanic acid oxidation in fibroblasts. In addition, elevated levels of bile acid intermediates have been reported in some cases. Plasmalogen synthesis, pipecolic acid levels, and subcellular distribution of catalase are normal. Using complementation analysis, we show that six patients. who were suspected of having a single enzyme defect in the peroxisomal β-oxidation pathway, are deficient in peroxisomal bifunctional enzyme [enoyl-CoA hydratase (EC 4.2.1. 17)/3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)] activity. This group of six patients, deficient in bifunctional enzyme activity, may be subdivided into two complementation groups. It would appear that patients in each of these two groups are deficient in only one of the bifunctional enzyme activities.
UR - http://www.scopus.com/inward/record.url?scp=0027286661&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027286661&partnerID=8YFLogxK
U2 - 10.1006/bmmb.1993.1025
DO - 10.1006/bmmb.1993.1025
M3 - Article
C2 - 8484962
AN - SCOPUS:0027286661
SN - 0885-4505
VL - 49
SP - 228
EP - 242
JO - Biochemical Medicine and Metabolic Biology
JF - Biochemical Medicine and Metabolic Biology
IS - 2
ER -